These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15863424)

  • 21. Closing in on ending the warfarin era for stroke prevention in nonvalvular atrial fibrillation.
    Turi ZG
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):223-4. PubMed ID: 19642149
    [No Abstract]   [Full Text] [Related]  

  • 22. No longer need to RE-LY on Warfarin for stroke prevention?
    Collins DR
    Ir Med J; 2009 Oct; 102(9):278-9. PubMed ID: 19902643
    [No Abstract]   [Full Text] [Related]  

  • 23. Cost-effectiveness of warfarin: trial versus "real-world" stroke prevention in atrial fibrillation.
    Sorensen SV; Dewilde S; Singer DE; Goldhaber SZ; Monz BU; Plumb JM
    Am Heart J; 2009 Jun; 157(6):1064-73. PubMed ID: 19464418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. More questions than answers for stroke prevention in the elderly with AF.
    Shiach C
    Age Ageing; 2005 Jan; 34(1):91-2. PubMed ID: 15591492
    [No Abstract]   [Full Text] [Related]  

  • 25. Will warfarin soon be passé? New approaches to stroke prevention in atrial fibrillation.
    Hammwöhner M; Goette A
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):18-27. PubMed ID: 18594479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stroke prevention in atrial fibrillation--pharmacologic strategies.
    Tiyyagura SR; Goldbarg SH; Mehta D
    Indian Heart J; 2007; 59(4):311-5. PubMed ID: 19126935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The BAFTA study].
    Di Pasquale G; Palareti G
    G Ital Cardiol (Rome); 2008 Nov; 9(11):735-9. PubMed ID: 19058663
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.
    Garwood CL; Corbett TL
    Ann Pharmacother; 2008 Apr; 42(4):523-32. PubMed ID: 18334606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrial fibrillation and stroke prevention.
    Kakar P; Lip GY
    Expert Rev Neurother; 2006 Oct; 6(10):1523-30. PubMed ID: 17078791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stroke prophylaxis in patients with atrial fibrillation: what can we do about it?
    Naunton M
    Eur Heart J; 2007 May; 28(9):1172-3; author reply 1173. PubMed ID: 17446229
    [No Abstract]   [Full Text] [Related]  

  • 32. Avoidance hierarchies and preferences for anticoagulation--semi-qualitative analysis of older patients' views about stroke prevention and the use of warfarin.
    Fuller R; Dudley N; Blacktop J
    Age Ageing; 2004 Nov; 33(6):608-11. PubMed ID: 15385273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensity of anticoagulation in octogenarians with nonvalvular atrial fibrillation.
    Jolobe OM
    J Am Geriatr Soc; 2008 Oct; 56(10):1967-8. PubMed ID: 19054207
    [No Abstract]   [Full Text] [Related]  

  • 34. [The importance of oral anticoagulation in patients with atrial fibrillation for stroke prevention].
    Neundörfer B
    Fortschr Neurol Psychiatr; 2008 Jul; 76(7):383-4. PubMed ID: 18604771
    [No Abstract]   [Full Text] [Related]  

  • 35. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation.
    Waldo AL; Becker RC; Tapson VF; Colgan KJ;
    J Am Coll Cardiol; 2005 Nov; 46(9):1729-36. PubMed ID: 16256877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative study of warfarin and aspirin for stroke prevention in elderly patients with atrial fibrillation].
    Han W; Shen DT; Wang YM
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):851-2, 855. PubMed ID: 16793618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of access to anticoagulation management services on warfarin use in patients with atrial fibrillation.
    Burkiewicz JS
    Pharmacotherapy; 2005 Aug; 25(8):1062-7. PubMed ID: 16207096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Automatic drug use audit in primary care--a pilot evaluation of warfarin use for patients with atrial fibrillation.
    Mortimer CL; Cottrell WN; Comino NJ
    Aust Fam Physician; 2005 Sep; 34(9):798-800. PubMed ID: 16184218
    [No Abstract]   [Full Text] [Related]  

  • 39. Warfarin and stroke outcomes in hemodialysis patients with atrial fibrillation.
    Genovesi S; Santoro A
    J Am Soc Nephrol; 2009 Oct; 20(10):2090-2. PubMed ID: 19713302
    [No Abstract]   [Full Text] [Related]  

  • 40. Managing the challenge of atrial fibrillation and stroke prevention in older people: new drugs or new approaches to improve outcomes?
    Fuller R; Dudley N
    Age Ageing; 2005 Jul; 34(4):413-4; author reply 414. PubMed ID: 15955767
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.